Skip to content
Clinical Trials – home
GreeceBack to Greece

Clinical trials in Ioannina

183 clinical trials in Ioannina, Greece. Every trial is listed in the EU Clinical Trials Register and updated daily.

Ioannina at a glance
183
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

183 trials in Ioannina

Open in trial search
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:LY3537031
  • Sponsor:Eli Lilly & Co.
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:LUNSEKIMIG
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Other cities in Greece

The busiest research cities in the country

All 50 cities in Greece

Clinical research in Ioannina

What the registry says about research in the country

01 Cardiovascular Research

Groundbreaking trials focusing on heart failure prevention and innovative treatments for cardiovascular diseases. Studies evaluating new combination therapies and investigating methods to reduce cardiovascular risks.

  • Heart Failure Prevention
  • Cardiovascular Disease Management
  • Deep Vein Thrombosis

Multiple trials exploring the effectiveness of novel medications in reducing cardiovascular events and improving patient outcomes.

02 Metabolic Disorders

Innovative research targeting obesity and various forms of hypercholesterolemia. Studies include treatments for both adult and pediatric patients with metabolic conditions.

  • Obesity Management
  • Dyslipidemia Treatment
  • Familial Hypercholesterolemia

Clinical investigations focusing on new therapeutic approaches for managing metabolic disorders and their complications.

03 Respiratory Medicine

Advanced studies in asthma and pulmonary fibrosis treatment. Research evaluating new medications for improving lung function and managing severe respiratory conditions.

  • Asthma Control
  • Pulmonary Fibrosis
  • Viral Lung Infections

Trials examining innovative therapies for both acute and chronic respiratory conditions.

04 Hematology

Research focusing on sickle cell disease and beta-thalassemia. Studies evaluating treatments for blood disorders and related complications.

  • Sickle Cell Disease Treatment
  • Iron Overload Management
  • Multiple Myeloma

Comprehensive trials investigating new therapeutic approaches for various blood disorders.

05 Neurological Conditions

Studies investigating treatments for multiple sclerosis and stroke prevention. Research focused on improving neurological outcomes and disease management.

  • Multiple Sclerosis
  • Stroke Prevention
  • Neurological Disorders

Trials evaluating innovative therapies for managing chronic neurological conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).